During the past decade, Shands Hospital at the University of Florida conducted 120 clinical trials. In the 10-year time frame, 120 clinical trials started and 69 clinical trials were completed, i.e. on average, 57.5% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 34 clinical trials were completed. i.e. 77.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shands Hospital at the University of Florida" #1 sponsor was "University of Florida" with 47 trials, followed by "Children's Oncology Group" with 22 trials sponsored, "Abbott Medical Devices" with 14 trials sponsored, "Medical College of Wisconsin" with 12 trials sponsored and "Pfizer" with 12 trials sponsored. Other sponsors include 137 different institutions and companies that sponsored additional 99 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shands Hospital at the University of Florida" #1 collaborator was "National Cancer Institute (NCI)" with 41 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 17 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 16 trials as a collaborator, "National Marrow Donor Program" with 16 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 10 trials as a collaborator. Other collaborators include 116 different institutions and companies that were collaborators in the rest 81 trials.

According to Clinical.Site data, the most researched conditions in "Shands Hospital at the University of Florida" are "Leukemia" (13 trials), "Lymphoma" (9 trials), "Sepsis" (8 trials), "Heart Failure" (7 trials) and "Cystic Fibrosis" (6 trials). Many other conditions were trialed in "Shands Hospital at the University of Florida" in a lesser frequency.

Most popular intervention types in "Shands Hospital at the University of Florida" are "Drug" (139 trials), "Device" (57 trials), "Other" (49 trials), "Procedure" (36 trials) and "Biological" (27 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "etoposide" (10 trials), "cyclophosphamide" (9 trials), "filgrastim" (9 trials) and "vincristine sulfate" (7 trials). Other intervention names were less common.

The vast majority of trials in "Shands Hospital at the University of Florida" are 239 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 55 active trials in "Shands Hospital at the University of Florida". 1 are not yet recruiting, 34 are recruiting, 16 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 160 completed trials in Shands Hospital at the University of Florida, undefined suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in Shands Hospital at the University of Florida, 21 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 54 trials that are defined as “Not Applicable".

Shands Hospital at the University of Florida has several departments that took part in Clinical trials: "UF Health Shands Children's Hospital" - 30 trials, "UF Health Shands Cancer Hospital" - 29 trials, "Thoracic and Cardiovasscular Surgery at UF Health" - 2 trials